A real‐world, observational study of erenumab for migraine prevention in Canadian patients

OBJECTIVES: To assess real‐world effectiveness, safety, and usage of erenumab in Canadian patients with episodic and chronic migraine with prior ineffective prophylactic treatments. BACKGROUND: In randomized controlled trials, erenumab demonstrated efficacy for migraine prevention in patients with ≤...

Descripción completa

Detalles Bibliográficos
Autores principales: Becker, Werner J., Spacey, Sian, Leroux, Elizabeth, Giammarco, Rose, Gladstone, Jonathan, Christie, Suzanne, Akaberi, Arash, Power, G. Sarah, Minhas, Jagdeep K., Mancini, Johanna, Rochdi, Driss, Filiz, Ayca, Bastien, Natacha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320807/
https://www.ncbi.nlm.nih.gov/pubmed/35403223
http://dx.doi.org/10.1111/head.14291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320807/
https://www.ncbi.nlm.nih.gov/pubmed/35403223
http://dx.doi.org/10.1111/head.14291

Ejemplares similares